Arcadia Biosciences Inc (RKDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 1,306 | 987 | 627 | 1,298 | 1,297 |
| Cost of Goods | 633 | 471 | 18 | 818 | 650 |
| Gross Profit | 673 | 516 | 609 | 480 | 647 |
| Operating Expenses | -674 | 2,575 | 11 | 2,695 | 2,751 |
| Operating Income | 1,980 | -1,588 | 616 | -1,397 | -1,454 |
| Other Income | -130 | 641 | 749 | 758 | 4,610 |
| Pre-tax Income | 1,850 | -947 | 1,365 | -639 | 3,156 |
| Income Tax | N/A | N/A | 9 | N/A | -1 |
| Net Income Continuous | 1,850 | -947 | 1,358 | -639 | 3,155 |
| Net Income Discontinuous | -789 | -1,476 | -4,211 | -1,928 | -2,337 |
| Minority Interests | N/A | N/A | N/A | N/A | -5 |
| Net Income | $1,061 | $-2,423 | $-2,853 | $-2,567 | $823 |
| EPS Basic Total Ops | 0.78 | -1.78 | 0.85 | -1.89 | 0.61 |
| EPS Basic Continuous Ops | 1.36 | -0.70 | 4.49 | -0.47 | 2.33 |
| EPS Basic Discontinuous Ops | -0.58 | -1.08 | -3.65 | -1.42 | -1.71 |
| EPS Diluted Total Ops | 0.78 | -1.78 | 0.85 | -1.89 | 0.61 |
| EPS Diluted Continuous Ops | 1.36 | -0.70 | 4.49 | -0.47 | 2.33 |
| EPS Diluted Discontinuous Ops | -0.58 | -1.08 | -3.65 | -1.42 | -1.71 |
| EPS Diluted Before Non-Recurring Items | 0.78 | -1.78 | -2.48 | N/A | N/A |
| EBITDA(a) | $2,160 | $-1,360 | $838 | $-1,130 | $-1,210 |